Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24860452 | 0.85 | MIF (0.36) | ALDH1A1LMNATP53 | |
| SCHEMBL20273044 | 0.76 | MGLL (0.35) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL19851854 | 0.76 | MGLL (0.59) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL21610368 | 0.76 | MGLL (0.59) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL22214489 | 0.76 | GBA1 (0.51) | HSP90AA1TLR9FAAHALDH1A1TP53 | |
| SCHEMBL19401650 | 0.74 | MGLL (0.57) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL20197866 | 0.74 | PTGS1 (0.40) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL16856543 | 0.74 | MGLL (0.34) | HSP90AA1TLR9FAAHALDH1A1LMNA | |
| SCHEMBL12629192 | 0.74 | PTGS1 (0.56) | LMNASMN1; SMN2 | |
| SCHEMBL26312049 | 0.74 | PTGS1 (0.56) | LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3797768-A1 | MALEIMIDE-FUNCTIONALISED PLATINUM FOR USE IN THE TREATMENT OF CANCER | Placon Therapeutics, Inc. (US) | 2021-03-31 | — | — | EP | disclosed |
| US-10322137-B2 | Platinum compounds, compositions, and uses thereof | PLACON THERAPEUTICS, INC. (US) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10322137-B2 | Platinum compounds, compositions, and uses thereof | BID, PDCD1LG2, CD274 | HSP90AA1 2920/4885TLR9 291/4885FAAH 4846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.